| |
| |
|
| Insider
Information: |
Sinha Vikas |
| Relationship: |
|
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,308,459 |
|
|
Indirect Shares
|
16,674,766 |
|
|
| Direct
Value |
$33,413,040 |
|
|
|
Indirect Value
|
$12,447,713 |
|
|
| Total
Shares |
17,983,225 |
|
|
| Total
Value |
$45,860,752 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
23
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
18
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -763.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP & CFO |
2016-08-08 |
178,463 |
2005-09-21 |
0 |
Premium* |
|
|
Allovir Inc |
ALVR |
|
2024-05-17 |
1,129,996 |
2024-05-17 |
16,674,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2005-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
officerTitle |
• – – |
2006-01-09 |
4 |
A |
$20.72 |
$82,880 |
D/D |
4,000 |
24,000 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2006-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,706 |
27,706 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• • – |
2007-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
32,706 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2008-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
33,044 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2009-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
66,197 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
54,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, CFO |
• – – |
2011-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
81,478 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-05-25 |
4 |
A |
$11.92 |
$53,688 |
D/D |
4,504 |
177,464 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
312,655 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,745 |
139,520 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
164,295 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2015-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
11,690 |
167,396 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,100 |
167,808 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,763 |
177,706 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
179,862 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2020-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
13,420,970 |
13,420,970 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • – |
2021-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
58,800 |
865,407 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • – |
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
48,838 |
907,795 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
29,400 |
939,656 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2022-07-28 |
4 |
A |
$4.61 |
$15,000,000 |
I/I |
3,253,796 |
16,674,766 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • – |
2022-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
1,038,224 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
157,500 |
1,187,738 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• • – |
2007-09-24 |
4 |
AS |
$63.00 |
$263,032 |
D/D |
(4,162) |
28,544 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr VP and CFO |
• – – |
2008-08-01 |
4 |
AS |
$92.28 |
$923,520 |
D/D |
(10,000) |
31,149 |
0 |
- |
|
145 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
